Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Harcourt

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical and Experimental Immunology|October 13, 2006
Identification of key peptide-specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populationsG C Harcourt, T J Scriba, N Semmo, et al.
European Journal of Immunology|October 28, 1997
Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptidesA K Sewell, G C Harcourt, P J Goulder, et al.
Clinical and Experimental Immunology|January 10, 2003
Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infectionG C Harcourt, M Lucas, A J Godkin, et al.
Journal of Medical Virology|January 1, 1980
Rubella immunity by four different techniques: results of challenge studiesJ M Best, G C Harcourt, A Druce, et al.
International Immunology|March 1, 1995
Human vascular endothelial cells process and present autoantigen to human T cell linesC O Savage, C J Brooks, G C Harcourt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cellsB Ong, N Willcox, P Wordsworth, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical and Experimental Immunology|October 13, 2006
Identification of key peptide-specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populationsG C Harcourt, T J Scriba, N Semmo, et al.
European Journal of Immunology|October 28, 1997
Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptidesA K Sewell, G C Harcourt, P J Goulder, et al.
Clinical and Experimental Immunology|January 10, 2003
Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infectionG C Harcourt, M Lucas, A J Godkin, et al.
Journal of Medical Virology|January 1, 1980
Rubella immunity by four different techniques: results of challenge studiesJ M Best, G C Harcourt, A Druce, et al.
International Immunology|March 1, 1995
Human vascular endothelial cells process and present autoantigen to human T cell linesC O Savage, C J Brooks, G C Harcourt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cellsB Ong, N Willcox, P Wordsworth, et al.
Pageof 2